| Market Cap | 3.80M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -4.95M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -39.00% |
| Sales | 1.81M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -38.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -90.00% |
| Recommedations | - | Quick Ratio | 0.38 | Shares Outstanding | 12.48M | 52W Low Chg | 17.00% |
| Insider Own | 80.00% | ROA | -74.23% | Shares Float | 3.71M | Beta | -1.60 |
| Inst Own | 0.80% | ROE | -768.84% | Shares Shorted/Prior | -/- | Price | 0.30 |
| Gross Margin | 54.84% | Profit Margin | -273.99% | Avg. Volume | 3,569 | Target Price | - |
| Oper. Margin | -248.47% | Earnings Date | - | Volume | 1 | Change | 0.00% |
Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Matine Charles | Director Director | Jun 09 | Buy | 0.60 | 180,555 | 108,333 | 206,985 | 06/21/23 |
| Gaston-Dreyfus Remi | Director Director | Jun 09 | Buy | 0.60 | 180,555 | 108,333 | 1,814,871 | 06/21/23 |
| AUBERTON-HERVE ANDRE-JACQUES | Director Director | Jun 09 | Buy | 0.60 | 650,000 | 390,000 | 923,160 | 06/21/23 |